Osmosis Investment Management UK Ltd acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 10,336 shares of the semiconductor company's stock, valued at approximately $4,611,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in Synopsys by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 18,464,862 shares of the semiconductor company's stock worth $8,673,315,000 after buying an additional 283,677 shares during the last quarter. BlackRock Inc. bought a new position in Synopsys during the second quarter worth $7,228,099,000. State Street Corp boosted its holdings in Synopsys by 0.3% in the fourth quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company's stock worth $4,128,317,000 after purchasing an additional 28,532 shares during the period. Morgan Stanley boosted its holdings in Synopsys by 2.5% in the fourth quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company's stock worth $2,148,491,000 after purchasing an additional 109,917 shares during the period. Finally, Geode Capital Management LLC increased its stake in Synopsys by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company's stock valued at $2,017,256,000 after purchasing an additional 54,329 shares during the last quarter. Institutional investors own 85.47% of the company's stock.
Insider Buying and Selling at Synopsys
In other news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company's stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.56% of the company's stock.
Wall Street Analysts Forecast Growth
SNPS has been the topic of a number of research reports. Benchmark reissued a "buy" rating on shares of Synopsys in a report on Wednesday. BNP Paribas Exane lifted their price target on shares of Synopsys from $425.00 to $450.00 and gave the company an "underperform" rating in a report on Thursday, May 28th. Berenberg Bank set a $633.00 price objective on shares of Synopsys in a research report on Wednesday, May 27th. Piper Sandler raised shares of Synopsys from a "neutral" rating to an "overweight" rating and raised their target price for the stock from $450.00 to $550.00 in a report on Tuesday, June 23rd. Finally, Citigroup lifted their target price on Synopsys from $600.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, May 28th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Synopsys currently has a consensus rating of "Moderate Buy" and a consensus target price of $563.59.
View Our Latest Analysis on SNPS
Synopsys Price Performance
Shares of NASDAQ:SNPS opened at $397.87 on Monday. The firm's 50 day moving average is $419.73 and its two-hundred day moving average is $440.09. Synopsys, Inc. has a 52 week low of $366.00 and a 52 week high of $615.79. The firm has a market capitalization of $76.18 billion, a P/E ratio of 92.10, a PEG ratio of 2.34 and a beta of 1.23. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts' consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company had revenue of $2.28 billion for the quarter, compared to analysts' expectations of $2.25 billion. During the same quarter in the previous year, the company posted $3.67 earnings per share. The business's revenue for the quarter was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current year.
About Synopsys
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
